300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Oil and Gas
InsurTech
Retail
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Sudan
Pakistan
Madagascar
Russian Federation
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Nicaragua
Namibia
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
El Salvador
Senegal
Sierra Leone
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Qatar
Austria
Azerbaijan
Bulgaria
Angola
Ecuador
Cyprus
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
asterX, VC Fund

asterX

VC Fund

Montréal, Canada

asterX is an arm of Quebecor’s corporate venture capital.

Total investments:
5
Last investment:
Lead investor:
0%

Last updated:

Industries asterX invests in

SaaSInternetSoftwareHealth CareMarketplace

Stages asterX invests in

SeedGrantSeries A

Countries asterX invests in

CanadaColombia

Investment Focus

Industry

  • SaaS 1 (20%)
  • Internet 1 (20%)
  • Software 1 (20%)
  • Health Care 1 (20%)
  • Marketplace 1 (20%)
See all 11 industries →

Stage

  • Seed 2 (40%)
  • Grant 1 (20%)
  • Series A 1 (20%)

Country

  • Canada 3 (60%)
  • Colombia 1 (20%)

Investments

CompanyDescriptionRoundLinks
Billdr Billdr
Billdr is an AI-native construction management platform for general contractors across North America, covering estimating, scheduling, job costing, invoicing, and client communication.Billdr brings your whole business under one roof, with an AI team built in: Bob, your AI project copilot, monitors every job in real time and flags risks beforethey become problems. Bruno, your AI estimator, builds accurate quotes in minutes from your price book. Send $100K+ quotes in 30 minutes or less. Billie, your AI receptionist (coming soon), will qualify leads, book calls, and follow up with prospects 24/7.Trusted by contractors managing $2B+ in projects across the US and Canada. $3.2M / Seed / Jan 26, 2026
BrainInnov BrainInnov
BrainInnov creates decision-supporting systems that aid in lifesaving and are based on artificial intelligence. $75K / Grant / Sep 16, 2025
Optable Optable
Optable is a data collaboration and clean room solution designed for the advertising ecosystem in the age of privacy. The product was inspired by the radical transformation in how audience data is governed, connected, and activated. Optable takes an end-to-end approach to data collaboration and is integrated with ad delivery platforms for secureactivation, making it possible to deploy campaigns directly from a clean room. It is the only clean room solution that offers frictionless collaboration and interoperability enabling customers to safely and securely match audience data with any partner. $20M / Series A / Jan 24, 2025
Optable Optable
Optable is a data collaboration and clean room solution designed for the advertising ecosystem in the age of privacy. The product was inspired by the radical transformation in how audience data is governed, connected, and activated. Optable takes an end-to-end approach to data collaboration and is integrated with ad delivery platforms for secureactivation, making it possible to deploy campaigns directly from a clean room. It is the only clean room solution that offers frictionless collaboration and interoperability enabling customers to safely and securely match audience data with any partner. $19.4M / Series A / Apr 18, 2023
Puzzle Medical Devices Puzzle Medical Devices
Puzzle Medical is developing the ModulHeart, a modular percutaneous heart pump designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure who are not candidates for heart transplant or surgical mechanical circulatory support. The device’s modular design allows for hemodynamic support through multiplepumps anchored in parallel in the descending aorta. The design is expected to increase accessibility by enabling safe percutaneous implantation to support both renal and cardiac function, with low risk of bleeding, stroke, and pump thrombosis, while providing sustained symptom relief, reduced re-hospitalizations and improved overall quality of life. To date, Puzzle Medical has successfully:○ completed its first-in-human study with all patients experiencing improvements in cardiac and kidney function (2022); ○ completed a Seed financing round (2021); ○ built a strong Key Opinion Leaders committee (2021); ○ received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation (2021). Seed / Jan 24, 2022

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
Oil and Gas
InsurTech
Retail
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
B2B
Blockchain
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Recruiting
Web3
Medical
Theatre
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Sudan
Pakistan
Madagascar
Russian Federation
Tajikistan
Zambia
Romania
Oman
Poland
Puerto Rico
Colombia
Cameroon
Guernsey
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Luxembourg
Mozambique
Malta
Mauritius
Nicaragua
Namibia
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Morocco
Moldova
Seychelles
Botswana
Paraguay
Canada
South Africa
France
Ireland
Denmark
Georgia
Ghana
Iraq
Latvia
Malaysia
Mali
Philippines
Rwanda
Portugal
El Salvador
Senegal
Sierra Leone
Tanzania
United States
India
Germany
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Argentina
Europe
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Qatar
Austria
Azerbaijan
Bulgaria
Angola
Ecuador
Cyprus
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does asterX invest in?

asterX invests primarily in SaaS, Internet and Software startups, most often at Seed and Grant stage. Most of the 5 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did asterX last invest?

The most recent investment recorded for asterX closed in Jan 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
asterX asterX Find emails